EHA and ASH Jointly Announce Translational Research Training in Hematology Program

This program will provide promising translational investigators an opportunity to receive intensive training in the causes, diagnosis, and experimental treatment of hematologic disorders from some of the most recognized names in the field.

“The next generation of translational researchers will need to understand how to direct research in both the European and U.S. systems,� said TRTH co-director and past ASH president Kenneth Kaushansky, MD. “This unique cross-cultural program provides participants with ongoing mentoring, a supportive peer network, and a depth of knowledge and experience that will help position them as global leaders in the field of translational research.�

The inaugural TRTH will bring 20 early-career scientists to Marbella, Spain, during the week of March 20-26, 2010. Practical sessions will focus on career development, featuring career retrospectives from leaders in the field of hematology and panel discussions on grant preparation and funding sources, while instructional sessions will prepare participants to conduct hypothesis-driven research, design phase I and II clinical trials, and utilize animal models, diagnostics, and biomarkers in translational research.

“This rigorous one-week training course will allow participants to work with faculty in small groups to review and refine their individual research proposals,� said program co-director and EHA president Willem Fibbe, MD. “The goal is for each of them to leave here with a competitive proposal so that they are ready to take the next step in applying for funding. We look forward to hearing about their progress when the group reconvenes at the EHA and ASH annual meetings.�

Medical trainees, biomedical trainees, and pharmaceutical doctorate trainees generally within 12 years of MD graduation or with less than eight years of post-doctoral experience are encouraged to apply; trainees must be an EHA or ASH member. Applications will be available on the EHA and ASH Web sites starting June 15, 2009.

Reporters who wish to learn more about the EHA-ASH Translational Research Training in Hematology program may contact Ineke van der Beek at +31 (0)10 4361760 or i.vanderbeek@ehaweb.org .

Contact

European Hematology Association, Executive Office Press Room ICC room 25-26; Nathalie van de Zande Telephone number during the congress: +49 3030 38 81 111 Mobile number Ineke van der Beek, External Affairs: +31 6 20 11 10 55 Telephone number after the congress: +31 (0)10 436 1760 E-mail: i.vanderbeek@ehaweb.org, n.vandezande@ehaweb.org

Patrick Irelan, American Society of Hematology E-mail: pirelan@hematology.org Telephone number: + 1 202-776-0544

The European Hematology Association (www.ehaweb.org) aims to promote excellence in clinical practice, research, and education in European hematology. Today, EHA – with over 3,000 active members from 95 countries – is a consolidated organization that pursues an extensive number of projects and programs. EHA has strong relationships with various National Societies in Europe and is perceived as the most important hematological association in Europa and beyond.

The American Society of Hematology (www.hematology.org) is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.